Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression

Area of Science:

• Neuroscience
• Regenerative Medicine
• Immunology

Background:

• Stem cell therapy aims to replace damaged tissue, but recent findings suggest secreted factors promote neurological recovery.
• Extracellular vesicles (EVs), including exosomes from stem cells, are implicated in mediating these restorative effects.
• Mesenchymal stem cells (MSCs) show therapeutic potential for post-stroke recovery, but their mechanisms are not fully understood.

Purpose of the Study:

• To compare the efficacy of MSC-derived EVs with MSCs in improving neurological impairment and brain remodeling after focal cerebral ischemia.
• To evaluate the long-term effects of MSC-EVs on motor coordination, brain injury, immune responses, and neurogenesis in a rodent stroke model.

Main Methods:

• Focal cerebral ischemia was induced in C57BL6 mice.
• Mice received either MSC-derived EVs (MSC-EVs) or MSCs intravenously at specific time points post-stroke.
• Neurological deficits, histological brain injury, peripheral immune responses, and cerebral angioneurogenesis were assessed up to 28 days post-stroke.

Main Results:

• MSC-EV administration resulted in improved neurological impairment and long-term neuroprotection, comparable to MSC treatment.
• Enhanced cerebral angioneurogenesis (angiogenesis and neurogenesis) was observed in stroke mice treated with MSC-EVs.
• MSC-EVs attenuated peripheral immunosuppression, including B-cell, NK cell, and T-cell lymphopenia, without affecting cerebral immune cell infiltration.

Conclusions:

• MSC-derived EVs are not inferior to MSCs in a rodent stroke model, demonstrating long-term neuroprotection and promoting neurological recovery.
• EVs modulate peripheral immune responses, creating a favorable environment for brain remodeling.
• Given their safety profile in humans, EVs represent a promising, innovative therapeutic strategy for stroke, potentially avoiding side effects associated with stem cell transplantation.